O
Omeat
Scalable cultivated meat
About Omeat
Omeat is pioneering a scalable and sustainable approach to producing cultured meat, which is real meat grown from cells outside the animal. This innovative method aims to address the environmental, health, and animal welfare challenges posed by traditional animal agriculture. By cultivating meat in a lab setting, Omeat provides a product that is just as delicious and nourishing as conventional meat, without the associated negative impacts. The company operates in the alternative protein market, targeting environmentally conscious consumers, health-focused individuals, and those concerned with animal welfare. Omeat's business model revolves around the production and sale of cultured meat products, generating revenue through direct sales to consumers and partnerships with food distributors and retailers. Led by Ali Khademhosseini, a top tissue engineer with a background at Harvard and MIT, Omeat is well-positioned to revolutionize the meat industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Thousand Oaks, United States
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 74.0/100
- Industry
- Food
- Sub-industry
- Innovative Food
- Sector
- Food, Spinout, Alternative Protein, Meat Substitute, Sustainable Development Goals, Lab-Grown, Climate Tech, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2025 | $0 | — | S2G Investments · Good Startup · Bold Capital Partners | ↗ |
| SERIES A✓Equity / VC | Apr 2022 | $31M | $122M | S2G Investments | — |
Growth signals
Latest recorded traffic for Omeat is 270 monthly website visits, up 50% over the last three months. Omeat's team grew 4.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
S2G Investments
Good Startup
Bold Capital Partners
Other known investors6 additional known investors
Terasaki Foundation Laboratory- CVCirque Ventures
Rethink Food
Rethink Venture Capital
Trailhead Capital
Voyager VC
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Omeat on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Omeat’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







